Long-term prehypertension treatment with losartan effectively prevents brain damage and stroke in stroke-prone spontaneously hypertensive rats

International Journal of Molecular Medicine
De-Hua HeJinxiu Lin

Abstract

Prehypertension has been associated with adverse cerebrovascular events and brain damage. The aims of this study were to investigate ⅰ) whether short‑ and long-term treatments with losartan or amlodipine for prehypertension were able to prevent blood pressure (BP)-linked brain damage, and ⅱ) whether there is a difference in the effectiveness of treatment with losartan and amlodipine in protecting BP-linked brain damage. In the present study, prehypertensive treatment with losartan and amlodipine (6 and 16 weeks treatment with each drug) was performed on 4-week‑old stroke-prone spontaneously hypertensive rats (SHRSP). The results showed that long-term (16 weeks) treatment with losartan is the most effective in lowering systolic blood pressure in the long term (up to 40 weeks follow-up). Additionally, compared with the amlodipine treatment groups, the short‑ and long-term losartan treatments protected SHRSP from stroke and improved their brains structurally and functionally more effectively, with the long-term treatment having more benefits. Mechanistically, the short‑ and long-term treatments with losartan reduced the activity of the local renin-angiotensin-aldosterone system (RAAS) in a time-dependent manner and more effectivel...Continue Reading

References

Dec 1, 1971·The American Journal of Physiology·D GantenJ Genest
Feb 1, 1971·The Journal of Experimental Medicine·C Fischer-FerraroS Finkielman
Oct 1, 1995·Hypertension·P HametJ Tremblay
Nov 1, 1996·Journal of Hypertension·E VacherJ F Giudicelli
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·L YuM C Dinauer
Sep 21, 2000·Pathophysiology : the Official Journal of the International Society for Pathophysiology·K Kannan, S K Jain
Mar 20, 2001·Nature Reviews. Molecular Cell Biology·M P Mattson
Feb 7, 2002·Zeitschrift für Gerontologie und Geriatrie·K Muradian, D O Schachtschabel
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Dec 4, 2003·American Journal of Hypertension·Yuko Takeda-MatsubaraMasatsugu Horiuchi
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Dec 14, 2004·The American Journal of Cardiology·Arch G MainousBrent M Egan
Jul 14, 2005·Journal of Neurochemistry·Jiping TangJohn H Zhang
Mar 16, 2006·The New England Journal of Medicine·Stevo JuliusUNKNOWN Trial of Preventing Hypertension (TROPHY) Study Investigators
Apr 4, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·M Ian Phillips, Edilamar Menezes de Oliveira
Jan 20, 2012·Current Opinion in Nephrology and Hypertension·Ulrike M SteckelingsThomas Unger
Apr 27, 2012·Pflügers Archiv : European journal of physiology·John W Wright, Joseph W Harding
Jun 26, 2012·Geriatrics & Gerontology International·Masaki Mogi, Masatsugu Horiuchi
Oct 6, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yili Wu, Weihong Song
Nov 28, 2012·Current Pharmaceutical Design·Toshihiro Ichiki

❮ Previous
Next ❯

Methods Mentioned

BETA
transmission electron microscopy

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.